Sam Brusco, Associate Editor06.08.21
AngioDynamics, maker of minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology earned 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for non-surgical removal of thrombi or emboli from the vasculature.
AngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021.
The company will report financial results for the fourth quarter and fiscal year 2021 before the market open on Tuesday, July 13, 2021. The company’s management will host a conference call at 8:00 a.m. ET to discuss the results.
AngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021.
The company will report financial results for the fourth quarter and fiscal year 2021 before the market open on Tuesday, July 13, 2021. The company’s management will host a conference call at 8:00 a.m. ET to discuss the results.